journal article·2023-07

Dual delivery of an NF-κB inhibitor and IL-10 through supramolecular hydrogels polarizes macrophages and promotes cardiac repair after myocardial infarction

Di Wang, Yang Hu, Lili Zhang, Haijian Cai, Yaguang Wang, Ye Zhang

Acta Biomaterialia· Volume 164
Publisher page

Abstract

The use of anti-inflammatory strategies has the potential to be a definitive treatment for ventricular remodeling post myocardial infarction (MI). The regulation of macrophage phenotypes by anti-inflammatory agents contributes to the alleviation of myocardial fibrosis. However, their poor retention rates severely affect treatment efficacy. Here, we propose a supramolecular compound, NapFFY, to co-assemble with IL-10 and SN50 as a novel anti-inflammatory SN50/IL-10/NapFFY hydrogel with cardioprotective properties. Results from the in vitro and in vivo experiments in murine cell line and rats, respectively, demonstrated that the SN50/IL-10/NapFFY hydrogel exhibits an ideal and sustained release of IL-10 and SN50. Intramyocardial injection of the SN50/IL-10/NapFFY hydrogel in a rat model of MI significantly inhibited the expression of proinflammatory cytokines. It promoted the polarization of M2 macrophages, which reduced cardiomyocyte apoptosis and improved vascularization at the border zones. Specifically, the SN50/IL-10/NapFFY hydrogel significantly improved heart function and ameliorated ventricular remodeling 28 days post MI. We envision that the SN50/IL-10/NapFFY hydrogel could serve as a new anti-inflammatory agent for the clinical treatment of MI in future studies. STATEMENT OF SIGNIFICANCE: Anti-inflammation is an ideal strategy for the treatment of ventricular remodeling post myocardial infarction (MI). SN50 and IL-10 have been shown to have diverse roles in antiinflammatory process, respectively. However, direct intravenous administration or intramyocardial injection of SN50 or IL-10 is not a viable option given its poor half-life in vivo. This study aimed to evaluate the synergistic cardioprotective effects of a supramolecular hydrogel loaded with an NF-κB inhibitor (SN50) and IL-10. Animal experiments showed that the SN50/IL-10/NapFFY hydrogels ameliorated the inflammatory microenvironment, and improved cardiac function to the infarct area in a rat model of MI. We anticipate that SN50/IL10NapFFY hydrogel could be used clinically to treat MI in the near future.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Cardiac Fibrosis and Remodeling · Cardiac Structural Anomalies and Repair · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (48)

Show source-provided references
1. Reducing the incidence and mortality from myocardial infarction10.1016/S2468-2667(22)00027-5 ↗
2. Long-term trends in the incidence of heart failure after myocardial infarction10.1161/CIRCULATIONAHA.108.784215 ↗
3. Heart disease and stroke statistics–2015 update: a report from the American Heart Association
4. The inflammatory response in myocardial injury, repair, and remodelling10.1038/nrcardio.2014.28 ↗
5. Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities10.1016/j.pharmthera.2018.01.001 ↗
6. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions10.1084/jem.20070885 ↗
7. Lgr4 governs a pro-inflammatory program in macrophages to antagonize post-infarction cardiac repair10.1161/CIRCRESAHA.119.315807 ↗
8. Macrophage plasticity, polarization, and function in health and disease10.1002/jcp.26429 ↗
9. Alternatively activated macrophages determine repair of the infarcted adult murine heart10.1172/JCI85782 ↗
10. Non-canonical alternatives: what a macrophage is 410.1084/jem.20120295 ↗
11. Soft apoptotic-cell-inspired nanoparticles persistently bind to macrophage membranes and promote anti-inflammatory and pro-healing effects10.1016/j.actbio.2021.07.002 ↗
12. Distinct macrophage phenotypes contribute to kidney injury and repair10.1681/ASN.2009060615 ↗
13. ROS-responsive polymer nanoparticles with enhanced loading of dexamethasone effectively modulate the lung injury microenvironment10.1016/j.actbio.2022.06.024 ↗
14. Monocyte and macrophage heterogeneity in the heart10.1161/CIRCRESAHA.113.300890 ↗
15. Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and Re-polarization10.1016/j.biomaterials.2020.120390 ↗
16. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR10.1161/CIRCRESAHA.108.188243 ↗
17. A DAMP-scavenging, IL-10-releasing hydrogel promotes neural regeneration and motor function recovery after spinal cord injury10.1016/j.biomaterials.2021.121279 ↗
18. Platelet-like fusogenic liposome-mediated targeting delivery of miR-21 improves myocardial remodeling by reprogramming macrophages post myocardial ischemia-reperfusion injury
19. The chemokine system in diverse forms of macrophage activation and polarization10.1016/j.it.2004.09.015 ↗
20. Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo10.1007/s10456-013-9381-6 ↗
21. The regulation of IL-10 production by immune cells10.1038/nri2711 ↗
22. IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation10.1007/s00395-017-0622-5 ↗
23. Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response10.1186/s12974-021-02316-7 ↗
24. High-dosage granulocyte colony stimulating factor treatment alters monocyte trafficking to the brain after experimental stroke10.1016/j.bbi.2016.08.008 ↗
25. Preconditioning to mild oxidative stress mediates astroglial neuroprotection in an IL-10-dependent manner10.1016/j.bbi.2012.12.016 ↗
26. Coacervate-mediated exogenous growth factor delivery for scarless skin regeneration10.1016/j.actbio.2019.03.052 ↗
27. IL-10 provides cardioprotection in diabetic myocardial infarction via upregulation of Heme clearance pathways10.1172/jci.insight.133050 ↗
28. Bortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitors10.1182/blood-2011-06-363911 ↗
29. Inhibitor of nuclear factor-kappaB, SN50, attenuates lipopolysaccharide-induced lung injury in an isolated and perfused rat lung model10.1016/j.trsl.2013.10.002 ↗
30. Modulation of nuclear factor-kappaB improves cardiac dysfunction associated with cardiopulmonary bypass and deep hypothermic circulatory arrest10.1097/CCM.0b013e318194ab65 ↗
31. Increased vaccine tolerability and protection via NF-kappaB modulation10.1126/sciadv.aaz8700 ↗
32. Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2
33. Protein release from gelatin matrices10.1016/S0169-409X(97)00125-7 ↗
34. Current strategies in extending half-lives of therapeutic proteins10.1016/j.jconrel.2019.02.016 ↗
35. Engineering growth factors for regenerative medicine applications10.1016/j.actbio.2015.11.007 ↗
36. Increased expression of pigment epithelium-derived factor in aged mesenchymal stem cells impairs their therapeutic efficacy for attenuating myocardial infarction injury10.1093/eurheartj/ehr131 ↗
37. Paracrine effect of regulatory T cells promotes cardiomyocyte proliferation during pregnancy and after myocardial infarction10.1038/s41467-018-04908-z ↗
38. Minimally invasive delivery of therapeutic agents by hydrogel injection into the pericardial cavity for cardiac repair10.1038/s41467-021-21682-7 ↗
39. Strontium ions protect hearts against myocardial ischemia/reperfusion injury10.1126/sciadv.abe0726 ↗
40. Natural Melanin/Alginate hydrogels achieve cardiac repair through ROS scavenging and macrophage polarization10.1002/advs.202100505 ↗
41. Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype
42. HIMF deletion ameliorates acute myocardial ischemic injury by promoting macrophage transformation to reparative subtype10.1007/s00395-021-00867-7 ↗
43. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction10.1161/CIRCULATIONAHA.109.916346 ↗
44. TGF-beta and the TGF-beta family: context-dependent roles in cell and tissue physiology10.1101/cshperspect.a021873 ↗
45. Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition10.1152/ajpheart.00370.2004 ↗
46. M1-like macrophage-derived exosomes suppress angiogenesis and exacerbate cardiac dysfunction in a myocardial infarction microenvironment10.1007/s00395-020-0781-7 ↗
47. Oxygen tension regulates the expression of angiogenesis factor by macrophages10.1126/science.6612342 ↗
48. Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis10.1161/CIRCRESAHA.113.301720 ↗